Balanced news tone
News Sentiment
0867 sentiment intelligence
China Medical System Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
87/100 classification confidence.
directly relevant articles
high-authority source matches
+3.2% over one week, +8.2% over four weeks, trend inactive, and near fair-value range.
China Medical System Wins Trial Nod for New AMD Drug CMS-D017
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
China Medical System Wins Trial Nod for New AMD Drug CMS-D017
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 10:46
- Source
- TipRanks
China Medical System Holdings Ltd. Actuals & Estimates (HKEX:867)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 13:34
- Source
- TradingView
How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 22 Jun 2026 07:00
- Source
- simplywall.st
China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- simplywall.st
China Medical System Stock - analyst consensus and strategy snapshot
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 17 Jun 2026 15:29
- Source
- ad-hoc-news.de
Zydus Lifesciences' Desidustat Receives NMPA Approval for Renal Anaemia Treatment in China
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 15 Mar 2026 07:00
- Source
- scanx.trade
Deloitte China assists listings of PATEO and HIPINE on SEHK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Sep 2025 12:42
- Source
- Deloitte
Deloitte China assists dual-primary listing of Hesai Group in SEHK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Sep 2025 07:00
- Source
- Deloitte
China Medical System’s Alzheimer’s Drug ZUNVYL Gains Approval in China
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 28 Jul 2025 07:00
- Source
- TipRanks
China Medical System debuts on SGX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2025 07:00
- Source
- Singapore Business Review
China Medical System shares surge 11% with its secondary listing on SGX
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2025 07:00
- Source
- The Business Times
China Medical System shares rise 11% with its secondary listing on SGX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2025 07:00
- Source
- The Straits Times
Deloitte China assists secondary listing of China Medical System on SGX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2025 07:00
- Source
- Deloitte
China Medical System eyes secondary listing on SGX in July
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2025 07:00
- Source
- Singapore Business Review
Hong Kong-listed China Medical System seeks secondary listing on SGX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2025 07:00
- Source
- The Business Times
China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2021 08:00
- Source
- ACN Newswire
Why This China Drug Play Must Be in Your Portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Sep 2015 07:00
- Source
- Barron's